Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement-positive non-small cell lung cancer: A case report

The resistance mechanisms to anaplastic lymphoma kinase (ALK) inhibitors comprise ALK gene variations, such as ALK point mutations and copy-number gains, the activation of bypass signaling through the activation of other oncogenes and small cell lung cancer (SCLC) transformation. To date, few studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Oya, Yuko, Yoshida, Tatsuya, Uemura, Takehiro, Murakami, Yoshiko, Inaba, Yoshitaka, Hida, Toyoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126188/
https://www.ncbi.nlm.nih.gov/pubmed/30214557
http://dx.doi.org/10.3892/ol.2018.9158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126188/
https://www.ncbi.nlm.nih.gov/pubmed/30214557
http://dx.doi.org/10.3892/ol.2018.9158

Ejemplares similares